CL2020003153A1 - Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016) - Google Patents

Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)

Info

Publication number
CL2020003153A1
CL2020003153A1 CL2020003153A CL2020003153A CL2020003153A1 CL 2020003153 A1 CL2020003153 A1 CL 2020003153A1 CL 2020003153 A CL2020003153 A CL 2020003153A CL 2020003153 A CL2020003153 A CL 2020003153A CL 2020003153 A1 CL2020003153 A1 CL 2020003153A1
Authority
CL
Chile
Prior art keywords
divisional application
antimicrobial compositions
compositions
effervescent agents
effervescent
Prior art date
Application number
CL2020003153A
Other languages
English (en)
Inventor
Danping Li
Original Assignee
Melinta Subsidiary Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2020003153(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Subsidiary Corp filed Critical Melinta Subsidiary Corp
Publication of CL2020003153A1 publication Critical patent/CL2020003153A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se relaciona con composiciones farmacéuticas que comprenden un agente antimicrobiano derivado de ácido quinolona carboxílico y un agente efervescente. Estas composiciones tienen tolerabilidad gastrointestinal mejorada y/o menos probabilidades de causar efectos secundarios gastrointestinales. Estas composiciones son útiles para la administración oral, para tratar, prevenir, o reducir el riesgo de infecciones microbianas.
CL2020003153A 2014-06-20 2020-12-03 Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016) CL2020003153A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462014786P 2014-06-20 2014-06-20

Publications (1)

Publication Number Publication Date
CL2020003153A1 true CL2020003153A1 (es) 2021-06-25

Family

ID=54868661

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2016003273A CL2016003273A1 (es) 2014-06-20 2016-12-20 Composiciones antimicrobianas con agentes efervescentes
CL2020003153A CL2020003153A1 (es) 2014-06-20 2020-12-03 Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2016003273A CL2016003273A1 (es) 2014-06-20 2016-12-20 Composiciones antimicrobianas con agentes efervescentes

Country Status (31)

Country Link
US (2) US20150366857A1 (es)
EP (3) EP3919057A1 (es)
JP (2) JP6995479B2 (es)
CN (2) CN106572982B9 (es)
AR (1) AR100920A1 (es)
AU (3) AU2015276954B2 (es)
BR (1) BR112016029761B1 (es)
CA (1) CA2952950C (es)
CL (2) CL2016003273A1 (es)
CR (2) CR20160592A (es)
CY (2) CY1121995T1 (es)
DK (2) DK3157510T3 (es)
EA (1) EA034152B1 (es)
EC (1) ECSP16095540A (es)
ES (2) ES2732865T3 (es)
HR (2) HRP20211685T1 (es)
HU (2) HUE056298T2 (es)
IL (1) IL249622A0 (es)
LT (2) LT3581180T (es)
MX (2) MX368940B (es)
PE (2) PE20210927A1 (es)
PH (1) PH12016502548A1 (es)
PL (2) PL3581180T3 (es)
PT (2) PT3581180T (es)
RS (2) RS59064B1 (es)
SI (2) SI3157510T1 (es)
SV (1) SV2016005349A (es)
TR (1) TR201909417T4 (es)
TW (2) TWI705814B (es)
UY (1) UY36184A (es)
WO (1) WO2015196027A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022240897A1 (en) * 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194617A (en) * 1988-12-17 1993-03-16 Meiji Seika Kaisha, Ltd. 2,3-disubstituted-4-hydroxyquinoline derivatives
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
BR9612862B8 (pt) 1995-09-22 2014-08-05 Wakunaga Pharma Co Ltd Derivado de ácido piridono carboxílico e agentes antibacteriais.
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
EP1281397A1 (en) * 1998-09-14 2003-02-05 Ranbaxy Laboratories Limited Orally administered controlled drug delivery system providing temporal and spatial control
US6187317B1 (en) * 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
WO2003101431A1 (en) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
EP2100892B1 (en) 2004-07-30 2014-04-23 AbbVie Inc. Preparation of pyridonecarboxylic acid antibacterials
PT3056492T (pt) 2004-10-08 2021-12-27 Abbvie Inc Sal de meglumina e formas cristalinas do mesmo de um fármaco (delafloxacina)
LT2486942T (lt) * 2004-11-24 2019-01-25 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai
ME02003B (me) * 2005-04-11 2012-12-31 Abbott Lab Farmaceutske smeše koje imaju unapređene profile rastvaranja za lekove koji su slabo rastvorljivi
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US20080171203A1 (en) * 2006-08-11 2008-07-17 Aqua Resources Corporation Nanoplatelet nickel hydroxides and methods of preparing same
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
RU2491075C2 (ru) * 2006-12-22 2013-08-27 Айронвуд Фармасьютикалз, Инк. Способы и композиции для лечения расстройств пищевода
CA2687192C (en) * 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
NZ593345A (en) * 2008-11-15 2013-04-26 Rib X Pharmaceuticals Inc Antimicrobial composition comprising a quinolone carboxylic acid derivative and a cyclodextrin
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
GB201020076D0 (en) * 2010-11-26 2011-01-12 Liverpool School Tropical Medicine Antimalarial compounds
NZ612909A (en) * 2011-01-10 2015-09-25 Infinity Pharmaceuticals Inc Processes for preparing isoquinolinones and solid forms of isoquinolinones
AU2012205419B2 (en) * 2011-01-14 2016-12-15 Spero Therapeutics, Inc. Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea
JP2013034468A (ja) * 2011-08-10 2013-02-21 Nisshin Sugar Mfg Co Ltd 発泡成型甘味料
EP2790678A4 (en) * 2011-12-16 2015-09-30 Celanese Eva Performance Polymers Inc CONTROLLED RELEASE EXCIPIENTS COMPRISING ETHYLENE COPOLYMERS, ETHYLCELLULOSES AND / OR THERMOPLASTIC POLYURETHANES
CN102697751A (zh) * 2012-05-30 2012-10-03 河南牧翔动物药业有限公司 一种畜禽专用恩诺沙星泡腾分散片及其制备方法

Also Published As

Publication number Publication date
ES2732865T3 (es) 2019-11-26
EP3581180B1 (en) 2021-08-04
SV2016005349A (es) 2017-08-31
PL3581180T3 (pl) 2022-02-07
CL2016003273A1 (es) 2017-08-04
CA2952950C (en) 2023-11-14
DK3581180T3 (da) 2021-11-08
ECSP16095540A (es) 2017-03-31
CY1125395T1 (el) 2023-03-24
JP6995479B2 (ja) 2022-01-14
AU2015276954B2 (en) 2020-07-23
BR112016029761A2 (pt) 2017-08-22
EP3919057A1 (en) 2021-12-08
HRP20211685T1 (hr) 2022-02-04
JP7149991B2 (ja) 2022-10-07
AU2021286284A1 (en) 2022-01-06
BR112016029761A8 (pt) 2021-06-29
EP3581180A1 (en) 2019-12-18
BR112016029761B1 (pt) 2023-03-07
CA2952950A1 (en) 2015-12-23
PE20210927A1 (es) 2021-05-19
PL3157510T3 (pl) 2019-12-31
IL249622A0 (en) 2017-02-28
AR100920A1 (es) 2016-11-09
TWI705814B (zh) 2020-10-01
PT3157510T (pt) 2019-06-21
EP3157510B1 (en) 2019-03-27
JP2017518349A (ja) 2017-07-06
AU2021286284B2 (en) 2024-02-29
PE20170304A1 (es) 2017-04-19
RS59064B1 (sr) 2019-08-30
JP2020183415A (ja) 2020-11-12
EP3157510A1 (en) 2017-04-26
TW201625249A (zh) 2016-07-16
CY1121995T1 (el) 2020-10-14
WO2015196027A1 (en) 2015-12-23
CN114831955B (zh) 2024-03-12
MX368940B (es) 2019-10-21
EA034152B1 (ru) 2020-01-09
HUE056298T2 (hu) 2022-02-28
CR20160592A (es) 2017-02-21
PT3581180T (pt) 2021-11-09
US20200237744A1 (en) 2020-07-30
LT3581180T (lt) 2021-12-27
TW202005650A (zh) 2020-02-01
AU2020256457B2 (en) 2021-09-30
CR20200565A (es) 2021-01-14
SI3581180T1 (sl) 2021-12-31
TR201909417T4 (tr) 2019-07-22
TWI732337B (zh) 2021-07-01
HRP20191133T1 (hr) 2019-09-20
HUE044764T2 (hu) 2019-11-28
PH12016502548A1 (en) 2017-04-10
MX2016017350A (es) 2017-04-06
ES2897576T3 (es) 2022-03-01
CN114831955A (zh) 2022-08-02
SI3157510T1 (sl) 2019-09-30
AU2015276954A1 (en) 2017-01-12
RS62538B1 (sr) 2021-12-31
AU2020256457A1 (en) 2020-11-12
US20150366857A1 (en) 2015-12-24
DK3157510T3 (da) 2019-07-01
CN106572982B9 (zh) 2022-07-08
MX2019012608A (es) 2019-12-02
EP3157510A4 (en) 2018-02-21
UY36184A (es) 2016-01-29
LT3157510T (lt) 2019-09-25
CN106572982B (zh) 2022-06-03
NZ727638A (en) 2023-08-25
EA201692532A1 (ru) 2017-05-31
CN106572982A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
SV2011003907A (es) Composiciones antimicrobianas
PE20150199A1 (es) Composiciones farmaceuticas y tratamiento de mastitis
BR112015018827A2 (pt) composição farmacêutica oral para tratamento de mucosite oral e estomatite
BR112017019413A2 (pt) combinação de agente bactericida com um agente alcalinizante lisossomotrópico para o tratamento de uma infecção bacteriana
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
BR112017014295A2 (pt) composição farmacêutica.
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
SV2016005348A (es) Mã‰todos para tratar infecciones
BR112018007374A2 (pt) composição farmacêutica
BR112016024236A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
MX2019007390A (es) Peptidos antimicrobianos y usos de los mismos.
CR20160591A (es) Metodos para tratar infecciones
UA101533U (uk) Полівалентний оральний гель для лікування і профілактики післяімплантаційних ускладнень
UA101950U (uk) Фармацевтична композиція для лікування і профілактики застуди
UA91125U (uk) Антибактеріальна композиція
EA201390764A1 (ru) Фармацевтические композиции